context
coptidi
rhizom
cr
also
known
huanglian
chines
rhizom
copti
chinensi
franch
c
deltoidea
cy
cheng
et
hsiao
c
teeta
wall
ranunculacea
wide
use
treat
bacillari
dysenteri
diabet
pertussi
sore
throat
aphtha
eczema
china
object
present
paper
review
latest
advanc
cr
focus
botani
phytochemistri
tradit
usag
pharmacokinet
pharmacolog
toxicolog
cr
futur
perspect
method
studi
review
book
phd
msc
dissert
state
local
drug
standard
pubm
cnki
scopu
web
scienc
googl
scholar
use
keyword
copti
coptidi
rhizoma
huanglian
goldthread
result
current
chemic
constitu
isol
identifi
cr
alkaloid
characterist
compon
togeth
organ
acid
coumarin
phenylpropanoid
quinon
extractscompound
isol
cr
cover
wide
pharmacolog
spectrum
includ
antibacteri
antiviru
antifung
antidiabet
anticanc
cardioprotect
effect
berberin
import
activ
constitu
primari
toxic
compon
cr
conclus
import
herbal
medicin
chines
medicin
cr
potenti
treat
variou
diseas
howev
research
undertaken
investig
clinic
effect
toxic
constitu
target
organ
pharmacokinet
establish
criteria
qualiti
control
cr
relat
medic
addit
activ
constitu
alkaloid
raw
process
product
cr
investig
articl
histori
wide
approxim
stamen
half
length
petal
anther
yellow
filament
narrowli
linear
flower
period
march
april
fruit
harvest
april
june
nativ
area
emei
hongya
sichuan
provinc
plant
grow
mountain
forest
altitud
approxim
flora
c
teeta
figur
c
often
use
folk
medicin
yunnan
provinc
china
perenni
herb
yellow
rhizom
yellow
dens
internod
mostli
fibrou
root
blade
compris
ovalshap
triangl
cm
long
cm
wide
tripl
fissur
c
teeta
one
two
scape
cm
high
fruit
period
bluegreen
infloresc
flower
yellowgreen
oval
calyx
mm
long
mm
wide
anther
mm
long
filament
mm
long
c
teeta
commonli
distribut
yunnan
tibet
provinc
china
burma
c
teeta
commonli
grow
shade
cold
damp
mountain
area
altitud
approxim
flora
major
morpholog
differ
among
rhizom
three
plant
weilian
curv
branch
cluster
shape
like
chicken
feet
yalian
less
branch
cylindr
yunlian
smallest
shape
like
scorpion
tail
review
mainli
discuss
advanc
research
cr
copti
chinensi
common
sourc
cr
first
investig
concern
chemic
compon
cr
succeed
isol
berberin
report
c
teeta
perrin
date
chemic
constitu
isol
identifi
alkaloid
abund
among
chemic
compon
consid
main
activ
ingredi
cr
besid
alkaloid
cr
contain
organ
acid
coumarin
phenylpropanoid
quinon
chemic
compon
section
structur
main
compound
cr
describ
drawn
tabl
figur
purpos
process
dynasti
refer
rub
fibrou
root
cloth
wash
remov
nonmedicin
part
impur
ensur
cur
effect
tang
dynasti
lei
stirbak
dark
brown
enhanc
efficaci
digest
invigor
function
spleen
song
dynasti
wang
carbon
stirfri
produc
hemostat
effect
qing
dynasti
chen
stirbak
loess
invigor
function
spleen
andstomach
jin
yuan
period
ming
dynasti
zhu
stirfri
wine
treat
insomnia
sore
mouth
red
swell
eye
song
dynasti
jin
yuan
period
zhu
stirfri
ginger
enhanc
effect
prevent
vomit
expel
phlegm
song
dynasti
wang
stirfri
bile
enhanc
function
clear
fire
liver
galllbladd
immers
rice
water
strengthen
role
nourish
spleen
harmon
spleen
stomach
han
treat
migrain
headach
nasal
flow
toothach
sore
throat
continu
noguchi
et
al
berberrubin
li
zf
et
al
coptisin
wang
et
al
palmatin
epiberberin
mizuno
et
al
columbamin
ikuta
itokawa
tetradehydroscoulerin
chen
et
al
jatrorrhizin
li
zf
et
al
groenlandicin
berberastin
li
zf
et
al
worenin
wang
et
al
zhao
et
al
yang
et
al
tetrahydroberberin
wang
et
al
hydroxid
one
noroxyhydrastinin
corydaldin
thalifolin
li
zf
et
al
dioxolo
benzoic
acid
methyl
ester
berbithin
coptisonin
tetrandrin
obamegin
magnoflorin
tomita
kura
sanguinarin
mizuno
et
al
norsanguinarin
oxysanguinarin
chilenin
yang
et
al
znferulyltyramin
li
zf
et
al
enferuloyltyramin
h
et
al
li
zf
et
al
hydroxymethyl
butano
h
et
al
carboxyl
cholin
lignan
woorenogenin
chen
et
al
woorenosid
yoshikawa
et
al
longifolrosid
meng
et
al
woorenosid
ii
yoshikawa
et
al
woorenosid
v
woorenosid
iii
woorenosid
iv
pinoresinol
medioresinol
pinoresinol
glucosid
obddiglucopyranosid
yoshikawa
et
syringaresinol
glucosid
meng
et
al
lariciresinol
hirano
et
al
dimethoxylariciresinol
methoxylariciresinol
lariciresinol
glucosid
r
obddiglucopyranosid
yoshikawa
et
lanicepsid
lanicepsid
b
isolariciresinol
woorenosid
xi
yoshikawa
et
cleomiscosin
mizuno
et
al
aquillochin
min
et
al
methyl
secoisolariciresinol
coniferylalcohol
ether
coniferyl
alcohol
ether
woorenosid
x
yoshikawa
et
continu
alkaloid
main
activ
ingredi
coptidi
isoquinolin
alkaloid
account
larg
proport
berberin
repres
compound
berberin
one
abund
ingredi
cooper
et
al
although
vari
differ
varieti
cr
addit
berberin
cr
contain
differ
kind
isoquinolin
alkaloid
divid
follow
subtyp
accord
structur
protoberberin
simpl
isoquinolin
aporphin
benzylisoquinolin
figur
protoberberin
alkaloid
deriv
benzylisoquinolin
phenol
oxid
coupl
isoquinolin
nmethyl
group
becom
berberin
bridg
carbon
tetracycl
ring
base
dibenzo
quinolizidin
system
form
main
matric
protoberberin
cooper
et
al
accord
posit
doubl
bond
whether
nitrogen
atom
posit
charg
protoberberin
divid
subtyp
shown
figur
follow
list
repres
protoberberin
compound
found
cr
among
subtyp
type
dihydrodehydrodiconiferyl
alcohol
wooreno
yoshikawa
et
simpl
phenylpropanoid
zoctadecyl
cafeat
acid
h
et
al
ferul
acid
li
xg
et
al
ethyl
ferul
yoshikawa
et
al
nbutyl
ferul
h
et
al
phydroxyphenethyl
eferul
hirano
et
al
acid
h
et
al
acid
methyl
ethyl
h
et
al
acid
butyl
ester
li
xg
et
al
acid
methyl
ethyl
acid
butyl
ester
h
et
al
chlorogen
acid
chen
l
et
al
methyl
nbutyl
h
et
al
hydroxyphenyl
lactic
acid
hydroxyphenyl
lactic
acid
yahara
et
al
yoshikawa
et
lactat
li
xg
et
al
lactat
h
et
al
lactat
propano
acid
flavonoid
meng
et
al
rhamnetin
wogonin
min
et
al
methoxydihydrochalcon
coptisid
fujiwara
et
al
coptisid
ii
woorenosid
xii
yoshikawa
et
compound
limonin
alcohol
li
xg
et
al
dihydroxyphenethyl
alcohol
yahara
et
al
meng
et
al
protocatechu
aldehyd
h
et
al
gentis
yahara
et
al
apocynol
h
et
al
li
zf
et
al
protocatechu
acid
meng
et
al
vanil
acid
li
zf
et
al
vanil
protocatechu
acid
methyl
ester
h
et
al
protocatechu
acid
ethyl
ester
wang
et
al
woorenosid
vi
yoshikawa
et
woorenosid
vii
woorenosid
viii
woorenosid
ix
cyclo
pheval
li
zf
et
al
cyclo
pheleu
bsitosterol
common
one
cr
berberin
berberrubin
coptisin
palmatin
epiberberin
columbamin
tetradehydroscoulerin
jatrorrhizin
groenlandicin
berberastin
worenin
tetrahydroscoulerin
hydroxid
yoshikawa
et
al
wang
et
al
li
zf
et
al
fan
et
al
wang
et
al
alkaloid
belong
subtyp
fuse
togeth
benzen
ring
pyridin
nitrogen
atom
posit
differ
quinolin
figur
simpl
isoquinolin
usual
smaller
molecular
weight
complex
branch
chain
simpl
isoquinolin
cr
includ
one
noroxyhydrastinin
corydaldin
thalifolin
li
zf
et
al
fan
et
al
benzylisoquinolin
divid
bisbenzylisoquinolin
compound
isoquinolin
matric
benzyl
group
posit
furthermor
bisbenzylisoquinolin
form
combin
two
via
ether
bond
dioxolo
benzoic
acid
methyl
ester
berbithin
coptisonin
tetrandrin
obamegin
cr
also
contain
subtyp
alkaloid
magnoflorin
tomita
kura
activ
ingredi
belong
aporphin
alkaloid
moreov
benzophenanthridin
alkaloid
also
found
certain
specif
cr
varieti
exampl
sanguinarin
norsanguinarin
oxysanguinarin
found
c
japonica
maiti
et
al
cr
also
includ
small
alkaloid
repres
compound
chilenin
znferulyltyramin
enferuloyltyramin
hydroxymethyl
butano
carboxyl
cholin
phenylpropanoid
class
compound
link
togeth
benzen
ring
threecarbon
chain
larg
class
organ
compound
exist
wide
exist
natur
medicin
subdivid
mani
differ
subclass
molecular
weight
phenylpropanoid
cr
vari
greatli
structur
phenylpropanoid
glycosid
report
cr
lignan
import
natur
constitu
variou
pharmacolog
activ
special
kind
phenylpropanoid
combin
two
simpl
phenylpropanoid
comprehens
investig
isol
cr
min
et
al
hirano
et
al
yoshikawa
chen
l
et
al
li
xg
et
al
wang
et
al
constitu
includ
woorenogenin
ferul
acid
deriv
common
simpl
phenylpropanoid
herbal
medicin
addit
ferul
acid
also
found
simpl
phenylpropanoid
deriv
usual
form
ester
carboxyl
group
yahara
et
al
yoshikawa
et
al
yoshikawa
et
al
hirano
et
al
chen
l
et
al
meng
et
al
fan
et
al
compound
includ
zoctadecyl
cafeat
acid
ferul
acid
previou
research
report
cr
also
contain
certain
flavonoid
mainli
includ
rhamnetin
wogonin
meng
et
al
min
et
al
coptisid
coptisid
ii
woorenosid
xii
fujiwara
et
al
yoshikawa
et
al
figur
compound
isol
cr
includ
limonin
yahara
et
al
yoshikawa
et
al
wang
et
al
li
xg
et
al
increas
research
devot
investig
antipathogen
microorgan
effect
cr
antibacteri
antivir
antifung
effect
comprehens
studi
valid
importantli
berberin
recogn
import
activ
monom
plant
tabl
berberin
inhibit
gramposit
g
bacteria
streptococcu
agalactia
staphylococcu
aureu
mutan
bacillu
anthraci
sui
enterococcu
faecium
choi
et
al
fan
et
al
wang
et
al
peng
et
al
gramneg
g
bacteria
actinobacillu
pleuropneumonia
shigella
dysenteria
kong
et
al
escherichia
coli
boberek
et
al
interestingli
alkaloid
isol
cr
especi
epiberberin
act
ureas
inhibitor
treat
helicobact
pylori
infect
chen
et
al
report
cr
extract
cre
significantli
inhibit
salmonella
typhimurium
minimum
bactericid
concentr
mbc
mgml
anoth
studi
report
although
cre
effect
bacteria
pseudomona
aeruginosa
proteu
mirabili
proteu
vulgari
process
ginger
show
mark
inhibitori
effect
bacteria
especi
p
aeruginosa
li
previou
studi
reveal
antibacteri
effect
cr
activ
constitu
attribut
damag
cell
membran
inhibit
protein
dna
synthesi
block
bacteri
divis
develop
disturb
format
zring
inhibit
cell
divis
protein
ftsz
xue
et
al
ming
et
al
antibacteri
effect
cr
alkaloid
g
bacteria
stronger
gbacteria
could
explain
differ
cell
membran
structur
pathogen
yong
et
al
perform
comprehens
analysi
includ
growth
rate
constant
k
maximum
power
output
log
phase
p
log
total
heat
output
log
phase
q
log
gener
time
g
growth
inhibitori
ratio
halfinhibitori
concentr
drug
ic
reveal
antibacteri
activ
e
coli
four
alkaloid
cr
order
berberin
coptisin
palmatin
jatrorrhizin
previou
investig
reveal
cr
berberin
inhibitori
effect
respiratori
syncyti
viru
influenza
viru
enteroviru
herp
simplex
viru
coronaviru
cytomegaloviru
addit
studi
show
inhibitori
effect
berberin
mediat
downregul
cellular
mention
dhamgay
et
al
cjun
ntermin
protein
kinas
jnk
nfkappa
b
activ
hayashi
et
al
suppress
mitogenactiv
protein
kinas
mapk
mapkerk
kinas
mek
extracellular
signalregul
kinas
erk
signal
shin
et
al
varghes
et
al
furthermor
berberin
could
suppress
autophagi
activ
akt
protein
inhibit
phosphoryl
jnk
iii
wang
hq
et
al
infect
could
also
suppress
water
extract
cr
main
alkaloid
serv
neuraminidas
inhibitor
among
palmatin
effect
ic
mm
specif
inhibit
west
nile
viru
wnv
proteas
viral
propag
palmatin
ic
mm
investig
palmatin
also
effect
dengu
viru
yellow
fever
viru
jia
et
al
berberin
show
weak
inhibitori
effect
c
albican
use
alon
combin
fluconazol
mic
valu
decreas
sharpli
lm
iwazaki
et
al
research
show
antifung
effect
berberin
base
abil
impair
mitochondri
function
gener
reactiv
oxygen
speci
ro
target
cell
wall
integr
pathway
affect
heat
shock
transcript
factor
dhamgay
et
al
cardiovascular
diseas
cvd
involv
heart
blood
vessel
lead
caus
death
worldwid
estim
million
peopl
die
cvd
year
mendi
et
al
importantli
cr
exert
signific
benefici
effect
major
risk
factor
cvd
includ
antiatherosclerot
antihyperlipidem
antidiabet
antihepat
steatotot
effect
recent
studi
shown
alkaloid
cr
protect
cvd
coronari
heart
diseas
myocardi
ischemiareperfus
injuri
heart
failur
arrhythmia
hypertens
feng
mei
yong
et
al
tabl
atherosclerosi
commonli
occur
subendotheli
space
intima
arteri
trigger
endotheli
dysfunct
subendotheli
lipoprotein
retent
taba
et
al
report
cr
main
alkaloid
berberin
coptisin
could
effect
prevent
develop
potenti
mechan
correl
suppress
ro
mediat
oxid
xu
rx
et
al
halt
chronic
inflammatori
reaction
via
inhibit
intracellular
inflamm
signal
pathway
particular
berberin
could
inhibit
atherogenesi
reduc
oxid
stress
express
adhes
molecul
aorta
increas
level
uncoupl
protein
anoth
cr
compon
magnoflorin
could
inhibit
coppermedi
cu
oxid
variou
lowdens
lipoprotein
ldl
form
increas
lag
time
conjug
dien
format
suppress
gener
thiobarbitur
acid
reactiv
substanc
tbar
hung
et
al
accumul
foam
cell
subendotheli
space
indispens
step
initi
progress
berberin
treatment
could
suppress
foam
cell
format
well
accumul
lipid
cholesterol
mechan
involv
activ
adenosin
amp
activ
protein
kinas
ampk
proliferatorsactiv
receptor
pparc
pathway
decreas
oxldl
uptak
chi
et
al
berberin
stabil
atherosclerot
plaqu
inhibit
express
matrix
metalloproteinas
extracellular
matrix
metalloproteinas
induc
emmprin
suppress
activ
pathway
hyperlipidemia
character
increas
level
blood
lipid
implic
contribut
factor
develop
cardiovascular
diseas
main
mechan
resist
hyperlipidemia
relat
inhibit
lipogenesi
promot
use
convers
excret
lipid
iii
et
al
alkaloid
deriv
cr
includ
berberin
coptisin
palmatin
epiberberin
jatrorrhizin
appear
prevent
bodi
weight
gain
reduc
serum
level
total
cholesterol
tc
triglycerid
tg
lowdens
lipoproteincholesterol
ldlc
increas
highdens
lipoproteincholesterol
hdlc
promot
excret
total
bile
acid
tba
faec
et
al
yang
w
et
al
effect
berberin
mainli
relat
upregul
ldl
receptor
ldlr
cytochrom
downregul
reductas
hmgcr
addit
palmatin
epibeberin
could
also
benefici
treat
hyperlipidaemia
downregul
apic
sodium
depend
bile
acid
transport
asbt
et
al
sterol
regulatori
elementbind
protein
srebp
transcript
factor
regul
cholesterol
bind
promot
gene
encod
ldlr
hmgcoa
synthas
interestingli
administr
coptisin
berberin
palmatin
could
activ
besid
main
alkaloid
cr
minor
alkaloid
berbamin
could
also
exert
effect
hypercholesterolem
zebrafish
upregul
cholesterol
transport
bile
acid
synthesi
obes
patholog
condit
character
excess
bodi
fat
often
lead
cardiovascular
diseas
ashraf
baweja
cell
commonli
use
detect
fat
metabol
previou
studi
reveal
five
cr
alkaloid
berberin
coptisin
palmatin
epiberberin
magnoflorin
could
inhibit
adipocyt
differenti
cellular
triglycerid
accumul
cell
downregul
adipocyt
marker
gene
includ
pparc
ccaatenhanc
bind
protein
cebp
choi
et
al
zhang
et
al
lipolysi
process
break
lipid
regard
target
treat
obes
adiponectin
involv
regul
metabol
process
bind
two
main
receptor
whose
express
level
decreas
develop
obes
berberin
treatment
upregul
express
consequ
elev
adiponectin
product
induc
lipolysi
berberin
could
also
directli
upregul
lipolysisrel
gene
encod
lpl
ppara
carnitin
palmitoyltransferas
mediumchain
acylcoa
dehydrogenas
mcad
nonalcohol
fatti
liver
diseas
type
hepat
steatosi
alway
involv
obes
report
mice
gut
microbiota
could
restor
gavag
mgkg
berberin
week
result
allevi
predispos
factor
liver
steatosi
effect
could
mediat
decreas
endotoxin
receptor
inflammatori
cytokin
interleukin
il
tumour
necrosi
factor
alpha
tnfa
find
consist
anoth
studi
suggest
berberin
action
larg
base
suppress
inflamm
independ
ampk
berberin
could
also
attenu
hepat
steatosi
enhanc
energi
expenditur
mice
induc
autophagi
fibroblast
growth
factor
express
howev
effect
abolish
defici
nutrient
sensor
furthermor
increas
evid
suggest
mechan
may
correl
global
modul
hepat
mrna
long
noncod
rna
lncrna
express
profil
reduc
endoplasm
reticulum
stress
er
stress
pathway
zhang
et
al
cardiac
ischemia
character
defici
suppli
blood
flow
energi
gener
nutrient
myocardium
steenbergen
frangogianni
effect
treatment
ischaem
heart
diseas
ihd
reperfus
heart
howev
reperfus
could
lead
seri
addit
injuri
term
ischaemia
reperfus
injuri
iri
wijck
buurman
cr
activ
compound
could
reduc
apoptosi
excess
autophagi
inflammatori
respons
regul
energi
metabol
improv
mitochondri
function
well
allevi
er
stress
might
combin
allevi
iri
berberin
treatment
could
improv
myocardi
infarct
injuri
cardiomyocyt
indic
decreas
creatin
kinas
isoenzym
ckmb
lactat
dehydrogenas
ldh
cardiac
troponin
ctni
reduc
oxid
stress
suppress
malondialdehyd
mda
product
promot
superoxid
dismutas
sod
liu
xt
et
al
zhang
et
al
vivo
vitro
experi
show
berberin
could
reduc
myocardi
infarct
size
improv
cardiac
function
suppress
myocardi
apoptosi
oxid
damag
er
stress
activ
signal
pathway
activ
ampk
signal
pathway
silent
inform
regul
signal
might
involv
antiautophagi
antiapoptosi
effect
berberin
jia
et
al
pressureoverloadinduc
cardiac
hypertrophi
berberin
inhibit
mtor
mapk
signal
pathway
enhanc
autophagi
consequ
attenu
left
ventricular
remodel
cardiomyocyt
apoptosi
li
mh
et
al
howev
excess
autophagi
activ
also
caus
cell
death
term
autophag
cell
death
also
known
typeii
program
cell
death
report
berberin
could
reduc
excess
autophagi
suppress
autophagyrel
protein
thu
protect
cell
hypoxiareoxygen
hr
induc
cell
death
huang
et
al
nonischem
area
diabet
anim
heart
berberin
increas
myocardi
glucos
uptak
glycolysi
fatti
acid
oxid
observ
berberin
could
act
muscarin
agonist
reduc
spontan
contract
rate
cardiomyocyt
cultur
might
contribut
understand
berberin
complex
action
heart
salehi
filtz
studi
shown
berberin
could
reduc
releas
tnfa
ilb
attenu
ischem
heart
injuri
activ
also
reduc
berberin
zhang
et
al
precondit
berberin
day
induct
ir
significantli
attenu
myocardi
ir
injuri
manifest
reduct
incid
ventricular
arrhythmia
amelior
myocardi
histolog
chang
effect
associ
suppress
signal
pathway
subsequ
reduct
express
relat
inflammatori
cytokinesi
serum
myocardi
tissu
zhu
li
berberin
could
inhibit
high
glucos
insulininduc
cardiomyocyt
hypertrophi
accompani
increas
nitric
oxid
synthas
no
activ
concentr
elev
ppara
eno
wang
et
al
coptisin
also
effect
myocardi
ischemia
reperfus
mir
injuri
suppress
myocardi
apoptosi
inflamm
via
inhibit
rhorock
pathway
inhibit
autophagosom
format
rather
induct
autolysosom
autophagi
event
wang
et
al
mainten
mitochondri
integr
one
critic
aspect
protect
myocardium
calo
et
al
berberin
could
improv
mitochondri
dysfunct
indic
increas
mitochondri
membran
potenti
mitochondri
complex
activ
decreas
releas
cytochrom
c
mitochondria
diabet
mellitu
dm
common
chronic
diseas
character
disord
glucos
metabol
serious
threaten
human
health
longev
shi
hu
earli
wei
jin
dynasti
ming
yi
bie
lu
record
treatment
cr
xiaok
proven
dm
cr
compon
exert
antidiabet
effect
improv
glucos
metabol
insulin
resist
ir
pancreat
beta
cell
modul
gut
microbiota
tabl
express
glucos
transport
protein
glut
key
factor
intracellular
transport
glucos
close
link
cellular
energi
metabol
huang
previou
report
reveal
treatment
berberin
glucos
uptak
fibroblast
cell
cell
line
express
reach
maximum
stimul
moreov
signific
activ
observ
within
min
reach
maximum
min
attribut
acut
activ
transport
activ
cok
et
al
level
protein
increas
cell
state
associ
activ
ampk
stimul
upregul
express
downregul
retinolbind
protein
also
involv
glucos
uptak
zhang
et
al
cell
line
use
test
glucos
consumpt
insulin
releas
respect
result
show
glucos
consumpt
cell
increas
berberin
insulin
independ
influenc
insulin
secret
anoth
studi
show
gnrhglucagonlik
mapk
pathway
intestin
might
involv
mechan
berberin
modul
glucos
metabol
insulin
resist
ir
patholog
condit
cell
fail
respond
normal
action
hormon
insulin
ir
increas
risk
develop
prediabet
dm
treatment
berberin
mgkgday
week
effect
featur
ir
syndrom
could
improv
level
ir
paramet
bodi
weight
hyperglycemia
hyperinsulinemia
hypercholesterolemia
hypertriglyceridemia
shen
et
al
reveal
berberin
could
decreas
insulin
level
pancreat
islet
bcell
via
revers
concentrationdepend
inhibit
promot
increas
express
insulin
receptor
insr
also
regard
target
berberin
increas
insulin
sensit
effect
relat
protein
kinas
c
pkc
depend
activ
promot
kong
wj
et
al
insulinresist
patient
diabet
phenomenon
increas
insr
dephosphoryl
protein
tyrosin
phosphatas
interestingli
berberin
suppress
activ
increas
phosphoryl
insr
insulin
receptor
substrat
ir
key
molecul
act
insulin
receptor
mediat
insulin
signal
insulin
signal
level
phosphoryl
akt
ir
significantli
increas
berberin
alloxaninduc
diabet
mice
xie
x
et
al
insulinresist
cell
berberin
improv
insulininduc
tyrosinephosphoryl
recruit
relat
inhibit
mtor
liu
lz
et
al
studi
report
berberin
could
promot
secret
insulin
increas
releas
stimul
pancreat
cell
intragastr
administr
berberin
restor
damag
pancrea
tissu
revers
decreas
number
islet
rat
dm
tang
et
al
chueh
lin
berberin
significantli
downregul
ratio
block
streptozotocin
stz
induc
apoptosi
mous
pancreat
islet
chueh
lin
berberin
cre
exert
similar
protect
effect
islet
b
cell
improv
islet
b
cell
prolifer
protein
level
inflamm
oxid
close
associ
dm
treatment
berberin
decreas
level
proinflammatori
cytokin
tnfa
ino
observ
jeong
et
al
lou
et
al
level
elev
diabet
anim
relat
cell
patient
level
ar
sod
gshpx
gsh
increas
mda
decreas
indic
oxid
inhibit
zhou
zhou
laoong
et
al
multipl
cellular
kinas
well
signal
pathway
mapk
ampk
nfjb
rho
gtpase
pathway
verifi
pivot
berberin
activ
reduc
oxid
stress
inflamm
treat
dm
xie
et
al
mo
et
al
howev
studi
show
berberin
could
decreas
hyperglycaemia
improv
impair
glucos
toler
increas
insulin
releas
synthesi
yin
et
al
chen
et
al
addit
berberin
recent
studi
show
polysaccharid
cr
increas
glucos
uptak
recov
glucos
toler
inhibit
format
advanc
glycat
end
product
reduc
oxid
jiang
et
al
cui
et
al
yang
et
al
recent
year
berberin
demonstr
treat
dm
modul
structur
divers
gut
microbiota
includ
enrich
benefici
microb
inhibit
harm
microb
bioavail
berberin
low
absorpt
rate
intestin
tract
howev
significantli
reduc
activ
disaccharidas
aglucosidas
intestin
tract
result
reduct
absorpt
glucos
postprandi
hyperglycemia
li
zq
et
al
cr
alkaloid
treatment
avoid
declin
divers
gut
microb
obes
mice
favour
mainten
stabl
healthi
bacteri
commun
highfat
high
cholesterol
hfhc
fed
anim
kai
berberin
lead
increas
abund
probiot
blautia
bacteroid
bifidobacteria
lactobacillu
decreas
rel
abund
firmicut
bacteroid
intestin
tract
anim
gu
et
al
anoth
studi
show
berberin
select
enrich
propion
acid
produc
bacteria
intestin
barrier
repair
bacteria
ackermansia
cr
decoct
promot
butyr
acid
produc
bacteria
coprococcu
faecalibacterium
oscillospira
compar
berberin
cr
decoct
induc
higher
flora
divers
flora
structur
closer
normal
anim
ti
increas
shortchain
fatti
acid
gut
may
account
structur
divers
chang
microbiota
induc
berberin
cancer
second
lead
caus
death
global
respons
million
death
global
nearli
death
caus
cancer
report
world
health
organ
studi
show
cr
berberin
effect
multipl
type
human
cancer
includ
bladder
breast
cervix
cholangiocarcinoma
colon
ehrlich
gastric
glioma
intestin
kidney
leukemia
liver
lung
nasopharyng
melanoma
myeloma
ovari
pancrea
prostat
sarcoma
ho
et
al
wang
n
et
al
cr
activ
ingredi
prevent
cancer
block
cell
cycl
inhibit
tumor
cell
prolifer
induc
apoptosi
inhibit
migrat
invas
enhanc
bodi
immun
function
tabl
berberin
induc
apoptosi
human
colon
carcinoma
cell
line
pancreat
cancer
cell
line
breast
cancer
cell
gener
ro
moreov
berberin
greater
apoptot
effect
cell
gemcitabin
hsu
et
al
xie
et
al
park
et
al
compar
chemic
drug
meloxicam
rosiglitazon
berberin
total
alkaloid
show
greater
apoptosisinduc
effect
ke
variou
apoptot
modul
signal
involv
induct
apoptosi
berberin
berberin
could
markedli
inhibit
express
survivin
cancer
cell
cancer
cell
et
al
activ
fadu
head
neck
squamou
cell
carcinoma
cell
malign
pleural
mesothelioma
yao
seo
et
al
berberin
also
regul
activ
bax
colon
cancer
cell
chidambara
et
al
cell
shukla
et
al
cancer
cell
kim
et
al
addit
signal
inhibit
liver
cancer
cell
colon
cancer
cell
li
et
al
li
c
et
al
berberin
also
promot
fasfasl
signal
pathway
trigger
activ
precursor
induc
apoptosi
human
oral
cancer
cell
colon
cancer
cell
berberin
enhanc
activ
bind
form
complex
increas
abil
bind
suggest
berberin
could
induc
autophag
cancer
cell
death
la
et
al
vitro
vivo
experi
show
coptisin
inhibit
prolifer
growth
migrat
hcc
cell
colorect
cancer
cell
promot
apoptosi
studi
show
coptisin
activ
microrna
chai
et
al
berberin
inhibit
express
cyclin
activ
relat
wnt
pathway
berberin
prevent
prolifer
lung
cancer
pg
cell
inhibit
cyclin
increas
number
cell
phase
decreas
number
cell
phase
phase
ye
berberin
block
human
gastric
carcinoma
cell
entranc
cell
cycl
phase
inhibit
colorect
adenocarcinoma
growth
induc
phase
arrest
sha
et
al
cai
et
al
howev
cr
berberin
decreas
number
cell
phase
significantli
number
cell
phase
increas
significantli
indic
cell
cycl
block
phase
cui
et
al
osteosarcoma
berberin
treatment
led
cell
cycl
arrest
cell
may
caus
arrest
cell
suggest
may
play
divers
role
cell
cycl
distribut
berberinetr
cancer
cell
addit
anoth
cr
compon
jatrorrhizin
could
inhibit
prolifer
neovascular
human
metastat
melanoma
cell
induc
cell
cycl
arrest
transit
moreov
columbamin
could
suppress
prolifer
neovascular
metastat
osteosarcoma
cell
low
cytotox
induc
cell
cycl
arrest
transit
associ
attenu
gene
express
phosphoryl
express
bao
et
al
urokinasetyp
plasminogen
activ
upa
mmp
play
import
role
cancer
metastasi
angiogenesi
inhibit
upa
mmp
could
inhibit
migrat
invas
cancer
cell
berberin
affect
jnk
mapk
nfjb
signal
pathway
inhibit
action
upa
human
tongu
squamou
carcinoma
cell
hepatoma
cell
breast
cancer
cell
ho
et
al
bing
et
al
kim
et
al
kuo
et
al
potenti
gene
associ
tumour
cell
metastasi
previou
research
indic
berberin
could
decreas
express
thu
reduc
metastasi
leukaemia
cell
liu
et
al
report
berberin
lm
could
act
rhogtpas
inhibitor
human
nasopharyng
carcinoma
cell
tang
et
al
inhibit
rhogtpas
cre
well
berberin
lm
might
also
result
blockad
rock
signal
hepatoma
cell
express
level
two
chemokin
receptor
involv
migrat
metastasi
esophag
cancer
cell
decreas
follow
berberin
treatment
mishan
et
al
tumour
angiogenesi
process
associ
invas
metastasi
essenti
link
control
tumour
progress
zhao
adjei
tumour
angiogenesi
vegf
hypoxiainduc
play
key
role
tumour
progress
vivo
vitro
studi
reveal
antiangiogen
activ
berberin
mediat
downregul
express
vegf
proinflammatori
mediat
hepatocellular
carcinoma
cell
breast
cancer
cell
hamsa
kuttan
kim
et
al
berberin
may
also
inhibit
adhes
gastric
cancer
cell
endotheli
cell
increas
proport
intercellular
adhes
mm
iizuka
et
al
molecul
vascular
cell
adhes
molecul
thu
reduc
risk
tumour
angiogenesi
induc
evodiamin
shi
et
al
addit
berberin
show
antiangiogenesi
effect
anim
orthotop
implant
hepatocellular
carcinoma
tsang
et
al
coptisin
mgkg
may
reduc
cancer
metastasi
risk
inhibit
raserk
pathway
bear
mice
chines
medicin
herb
enhanc
bodi
immun
function
induc
cytokin
interferon
ifn
lymphocyteactiv
killer
cell
product
natur
killer
nk
cell
prolifer
therebi
mediat
tumor
cell
apoptosi
importantli
cre
could
markedli
increas
ifnb
tnfa
mrna
express
breast
cancer
oestrogen
receptorposit
cell
kang
et
al
furthermor
berberin
also
capabl
reduc
express
osteosarcoma
cell
inhibit
growth
tumour
cell
suggest
mechan
might
involv
downregul
inflammatori
signal
axi
recent
studi
show
palmatin
disrupt
interact
pancreat
stellat
cell
cancer
cell
tumour
microenviron
consequ
result
inhibit
cancer
growth
migrat
induc
apoptosi
inhibit
survivin
chakravarthi
et
al
experiment
studi
show
cr
compound
could
use
treat
diseas
nervou
system
digest
system
skeleton
skin
hepatotox
nephrotox
agingrel
disord
lee
et
al
su
et
al
berberin
could
amelior
bamyloid
patholog
gliosi
cognit
impair
alzheim
diseas
transgen
mous
model
signal
pathway
induc
human
dopaminerg
neuron
cell
death
induct
exert
antidepress
action
inhibit
organ
cation
transport
durairajan
et
al
bae
et
al
sun
et
al
furthermor
cr
could
treat
alzheim
diseas
via
signific
inhibit
acetylcholinesteras
ach
kaufmann
et
al
cre
coptisin
jatrorrhizin
display
neuroprotect
effect
allevi
oxid
stress
friedemann
et
al
friedemann
et
al
luo
et
al
berberin
prevent
glucocorticoidinduc
bone
loss
lumbar
spongi
bone
promot
bone
format
inhibit
bone
resorpt
bilian
et
al
cre
radioprotect
effect
radiationinduc
skin
damag
rat
modul
oxid
stress
skin
agingrel
diseas
via
antioxid
ampk
activ
wang
xj
et
al
xu
z
et
al
digest
system
cr
extract
could
exert
analges
effect
rat
model
irrit
bowel
syndrom
decreas
serotonin
releas
cholecystokinin
express
tjong
et
al
coptisin
show
signific
gastric
mucos
protect
effect
stress
gastric
ulcer
mice
howev
protect
effect
coptisin
mgkg
gastric
mucosa
significantli
better
mgkg
berberin
feng
et
al
jatrorrhizin
delay
gastric
empti
intestin
transit
postop
ileu
berberin
potenti
allevi
premenopaus
syndrom
decreas
oxid
stress
ldl
triglycerid
insulin
resist
improv
mood
caliceti
et
al
current
pharmacokinet
research
cr
mainli
focus
protoberberin
alkaloid
oral
intak
blood
exposur
absolut
bioavail
extrem
low
absorpt
berberin
undergo
extens
firstpass
elimin
absorb
alkaloid
quickli
wide
distribut
tissu
brain
intestin
stomach
pancrea
heart
kidney
liver
spleen
lung
testicl
uteru
among
liver
highest
concentr
et
al
furthermor
concentr
alkaloid
tissu
higher
circul
also
elimin
slower
rate
research
analys
metabolit
urin
fece
plasma
intestin
flora
found
mainli
compris
sulphat
glucuronid
conjug
cr
alkaloid
phase
metabolit
alkaloid
liver
microsom
cytochrom
isoenzym
cyp
play
major
role
intestin
flora
also
exert
signific
effect
enterohepat
circul
metabolit
may
relat
multipl
peak
phenomenon
pharmacokinet
cr
alkaloid
zuo
et
al
berberin
usual
excret
urin
bile
studi
show
berberin
elimin
directli
urin
oral
administr
yu
et
al
metabolit
mainli
elimin
via
urin
aproport
also
elimin
bile
zuo
et
al
howev
patholog
condit
diabet
mellitu
piib
postinflamm
irrit
bowel
syndrom
lipopolysacchariderel
diseas
pharmacokinet
process
alter
yu
et
al
show
higher
exposur
berberin
palmatin
coptisin
epiberberin
jatrorrhizin
increas
c
max
maximum
concentr
increas
auc
area
curv
diabet
rat
oral
administr
cre
g
kg
discov
impair
function
express
pglycoprotein
intestin
partli
contribut
increas
exposur
five
protoberberin
alkaloid
oral
intak
berberin
auc
mice
piib
higher
normal
mice
total
bodi
clearanc
decreas
significantli
gong
et
al
pharmacokinet
studi
magnoflorin
show
lower
bioavail
faster
absorpt
elimin
howev
pharmacokinet
paramet
alter
remark
magnoflorin
administ
cr
decoct
oral
gavag
cr
decoct
decreas
absorpt
elimin
rate
magnoflorin
reveal
pharmacokinet
interact
magnoflorin
rest
ingredi
cr
berberin
plasma
quickli
elimin
intraven
inject
cr
howev
berberin
could
penetr
bloodbrain
barrier
bbb
reach
hippocampu
rapid
increas
slow
elimin
tabl
cr
ban
singapor
recent
decad
suggest
berberin
aggrav
jaundic
kernicteru
neonat
dehydrogenas
defici
wong
research
found
organ
toxic
electrolyt
imbal
patient
administ
cr
daili
dose
g
patientday
linn
et
al
ban
chines
herbal
medicin
rich
berberin
offici
lift
nevertheless
toxic
ignor
acut
toxic
studi
show
oral
medial
lethal
dose
ld
fibrou
root
cr
greater
mgkg
bodi
weight
kunm
mice
subchron
toxic
studi
show
noobservedadvers
effect
level
noael
gkg
bodi
weight
rat
wherea
gkg
bodi
weight
result
liver
lung
damag
ame
test
mous
micronucleu
test
mous
sperm
abnorm
test
provid
neg
result
ning
et
al
median
acut
oral
lethal
dose
cre
gkg
mice
howev
alkaloidrich
extract
much
toxic
total
extract
cr
et
al
anoth
studi
ld
valu
four
alkaloid
berberin
coptisin
palmatin
epiberberin
determin
mgkg
respect
likewis
cytotox
berberin
highest
palmatin
lowest
toward
cell
subchron
toxic
studi
mortal
morbid
observ
yi
et
al
determin
noael
toxic
cr
rat
receiv
repeat
oral
administr
cr
week
mortal
remark
clinic
sign
observ
studi
noael
cr
determin
mgkgday
male
rat
mgkgday
femal
rat
lee
et
al
oral
berberin
caus
respiratori
failur
extrapyramid
system
reaction
sever
arrhythmia
liver
function
injuri
even
death
clinic
china
believ
caus
inhibitori
effect
human
eagrel
gene
herg
potassium
channel
induct
mitochondri
dysfunct
pereira
et
al
schramm
et
al
furthermor
author
report
ach
inhibitor
significantli
increas
acut
toxic
cre
wherea
cholinesteras
reactiv
significantli
decreas
acut
toxic
therefor
author
suggest
acut
toxic
oral
cr
extract
relat
ach
inhibit
et
al
take
find
togeth
conclud
toxic
constitu
cr
alkaloid
mainli
berberin
howev
toxic
mechan
cr
alkaloid
may
complic
remain
determin
current
recommend
dose
cr
alkaloid
cr
consumpt
rel
safe
ho
et
al
fact
cr
seldom
use
alon
clinic
instead
usual
prescrib
medicin
could
reduc
toxic
effect
herbal
medicin
includ
tcm
consid
use
agent
treat
variou
human
diseas
peng
et
al
cr
long
histori
use
import
herbal
medicin
asian
countri
reliabl
cur
effect
variou
diseas
nowaday
predomin
tradit
use
cr
confirm
modern
pharmacolog
research
far
investig
report
cr
contain
abund
isoquinolin
alkaloid
especi
berberin
also
activ
substanc
respons
pharmacolog
effect
tcm
cr
berberin
broadspectrum
antibacteri
effect
manifest
bacteriostasi
low
concentr
steril
high
concentr
suggest
combin
berberin
cr
convent
antibacteri
drug
might
exert
greater
effect
intens
research
indic
cr
potenti
cardioprotect
agent
addit
reduc
incid
also
protect
heart
mir
injuri
properti
mainli
attribut
berberin
coptisin
palmatin
epiberberin
jatrorrhizin
magnoflorin
mani
studi
demonstr
modul
composit
gut
microbiota
enrich
benefici
microbiota
inhibit
harm
microbiota
one
import
aspect
treat
obes
diabet
metabol
disord
natur
compound
antiinflammatori
antitumor
activ
berberin
show
great
potenti
cancer
treatment
howev
effect
berberin
strong
therefor
structur
modif
berberin
requir
moreov
cr
contain
variou
activ
compon
may
effect
singl
compon
berberin
could
provid
multipl
therapeut
effect
signific
differ
blood
concentr
tissu
concentr
therefor
find
suitabl
pharmacokinet
marker
cr
may
challeng
necessari
moreov
pharmacokinet
tcm
tri
elucid
chemic
compon
enter
bodi
process
bodi
absorpt
distribut
metabol
excret
aim
build
bridg
complex
chemic
compon
system
clinic
effect
reveal
underli
mechan
addit
relat
targetorgan
toxic
evalu
lack
thu
work
devot
investig
pharmacokinet
featur
cr
activ
compon
clinic
studi
requir
evalu
potenti
cur
effect
possibl
toxic
cr
activ
compon
toward
target
organ
addit
accord
current
pharmacolog
research
berberin
main
activ
compon
also
primari
toxic
compon
cr
consequ
crucial
develop
strategi
balanc
pharmacolog
effect
toxic
berberin
besid
current
report
origin
plant
use
make
cr
includ
c
chinensi
c
deltoidea
c
teeta
commonli
focu
chemic
compon
pharmacolog
effect
root
tradit
use
tcm
part
plant
often
ignor
dispos
without
pretreat
shen
howev
previou
report
reveal
leav
cr
plant
also
contain
berberin
li
et
al
liu
et
al
therefor
research
requir
investig
chemic
constitu
pharmacolog
activ
part
origin
cr
plant
present
studi
systemat
review
tradit
use
botani
phytochemistri
pharmacolog
toxicolog
cr
provid
comprehens
inform
regard
herbal
medicin
could
benefici
highlight
import
cr
provid
clue
futur
research
herbal
medicin
author
provid
consent
public
pharmaceut
biolog
author
person
financi
conflict
interest
associ
work
work
support
sichuan
provinci
administr
tradit
chines
medicin
